Cat. No：GM-C19190
Product：H_DLL4 CHO-K1 Cell Line
Cat. No：GM-C19190
Product：H_DLL4 CHO-K1 Cell Line
Cell Growth Medium：F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Cell Freezing Medium：90% FBS+10% DMSO
H_DLL4 amino acid sequence (Q9NR61-1)：
MAAASRSASGWALLLLVALWQQRAAGSGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQAVVSPGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIEAWHAPGDDLRPEALPPDALISKIAIQGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHFGHYVCQPDGNLSCLPGWTGEYCQQPICLSGCHEQNGYCSKPAECLCRPGWQGRLCNECIPHNGCRHGTCSTPWQCTCDEGWGGLFCDQDLNYCTHHSPCKNGATCSNSGQRSYTCTCRPGYTGVDCELELSECDSNPCRNGGSCKDQEDGYHCLCPPGYYGLHCEHSTLSCADSPCFNGGSCRERNQGANYACECPPNFTGSNCEKKVDRCTSNPCANGGQCLNRGPSRMCRCRPGFTGTYCELHVSDCARNPCAHGGTCHDLENGLMCTCPAGFSGRRCEVRTSIDACASSPCFNRATCYTDLSTDTFVCNCPYGFVGSRCEFPVGLPPSFPWVAVSLGVGLAVLLVLLGMVAVAVRQLRLRRPDDGSREAMNNLSDFQKDNLIPAAQLKNTNQKKELEVDCGLDKSNCGKQQNHTLDYNLAPGPLGRGTMPGKFPHSDKSLGEKAPLRLHSEKPECRISAICSPRDSMYQSVCLISEERNECVIATEV
| DLL4 | ||
| Cynomolgus_DLL4 CHO-K1 Cell Line | H_DLL4 HEK-293 Cell Line | |
| Anti-DLL4 hIgG1 Antibody(MLCK-2(ABL-001)) | Anti-DLL4 hIgG2 Antibody(Navicixizumab) | |
| DLL3 | ||
| Cynomolgus_DLL3 CHO-K1 Cell Line | H_DLL3 CHO-K1 Cell Line | H_DLL3 HEK-293 Cell Line |
| Anti-DLL3 hIgG1 Reference Antibody(Rovabio) | Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab) | |
| Cynomolgus DLL3 Protein; His Tag | Human DLL3 Protein; His Tag | |
Cat. No：GM-C19190
Product：H_DLL4 CHO-K1 Cell Line
Cell Growth Medium：F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Cell Freezing Medium：90% FBS+10% DMSO
H_DLL4 amino acid sequence (Q9NR61-1)：
MAAASRSASGWALLLLVALWQQRAAGSGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQAVVSPGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIEAWHAPGDDLRPEALPPDALISKIAIQGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHFGHYVCQPDGNLSCLPGWTGEYCQQPICLSGCHEQNGYCSKPAECLCRPGWQGRLCNECIPHNGCRHGTCSTPWQCTCDEGWGGLFCDQDLNYCTHHSPCKNGATCSNSGQRSYTCTCRPGYTGVDCELELSECDSNPCRNGGSCKDQEDGYHCLCPPGYYGLHCEHSTLSCADSPCFNGGSCRERNQGANYACECPPNFTGSNCEKKVDRCTSNPCANGGQCLNRGPSRMCRCRPGFTGTYCELHVSDCARNPCAHGGTCHDLENGLMCTCPAGFSGRRCEVRTSIDACASSPCFNRATCYTDLSTDTFVCNCPYGFVGSRCEFPVGLPPSFPWVAVSLGVGLAVLLVLLGMVAVAVRQLRLRRPDDGSREAMNNLSDFQKDNLIPAAQLKNTNQKKELEVDCGLDKSNCGKQQNHTLDYNLAPGPLGRGTMPGKFPHSDKSLGEKAPLRLHSEKPECRISAICSPRDSMYQSVCLISEERNECVIATEV
| DLL4 | ||
| Cynomolgus_DLL4 CHO-K1 Cell Line | H_DLL4 HEK-293 Cell Line | |
| Anti-DLL4 hIgG1 Antibody(MLCK-2(ABL-001)) | Anti-DLL4 hIgG2 Antibody(Navicixizumab) | |
| DLL3 | ||
| Cynomolgus_DLL3 CHO-K1 Cell Line | H_DLL3 CHO-K1 Cell Line | H_DLL3 HEK-293 Cell Line |
| Anti-DLL3 hIgG1 Reference Antibody(Rovabio) | Anti-H_DLL3 hIgG1 Antibody(Rovalpituzumab) | |
| Cynomolgus DLL3 Protein; His Tag | Human DLL3 Protein; His Tag | |
